Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial

Abstract

The use of 0.01% atropine eye drop reduced the progression of myopia over the study period of one year with no significant changes in near vision, pupil size. No patient reported any systemic and local side effects with administration of 0.01% atropine eye drop.